SemBioSys Genetics (original) (raw)
SemBioSys Genetics Inc. was a development stage agricultural biotechnology company. It utilized its patented safflower pharming platform to develop and make proteins and oils for the nutraceutical, functional food and beverage, and pharmaceutical industries. A University of Calgary spin-off (1994), SemBioSys became a publicly traded firm. Investors had included Bay City Capital, the Business Development Bank of Canada, Dow AgroSciences (a Canadian subsidiary of The Dow Chemical Company), Royal Bank Ventures Inc. (now RBC Capital Partners), the University of Calgary, Ventures West Capital Ltd., and Dr. Maurice Moloney. In May 2012, SemBioSys terminated its operations.
| Property | Value |
|---|---|
| dbo:abstract | SemBioSys Genetics Inc. was a development stage agricultural biotechnology company. It utilized its patented safflower pharming platform to develop and make proteins and oils for the nutraceutical, functional food and beverage, and pharmaceutical industries. A University of Calgary spin-off (1994), SemBioSys became a publicly traded firm. Investors had included Bay City Capital, the Business Development Bank of Canada, Dow AgroSciences (a Canadian subsidiary of The Dow Chemical Company), Royal Bank Ventures Inc. (now RBC Capital Partners), the University of Calgary, Ventures West Capital Ltd., and Dr. Maurice Moloney. In May 2012, SemBioSys terminated its operations. The company's strategy was to partner with other companies to enable the commercialization of products. Its lead pharmaceutical products under development were biosimilar insulin and Apo AI(Milano). In a phase I/II clinical trial, SemBioSys demonstrated that its safflower produced insulin (SBS-1000) is bioequivalent to humulin, a commercially available insulin. In 2007, SemBioSys formed a subsidiary, Botaneco Specialty Ingredients Inc., dedicated to the commercialization of SemBioSys’ products for cosmetic, personal care and prescription topical dermatology products. Botaneco produced, marketed, and sold its products under the brand name Hydresia. In October 2009, Botaneco merged with Quebec City-based Advitech, a health sciences and technology company. In October 2011, SemBioSys signed a collaboration agreement with Tasly Pharmaceuticals of Tianjin (China) and its wholly owned subsidiary Tasly U.S. Tasly is of China's top five largest producers of traditional Chinese medicines (TCMs). Upon government approval, a new company called Tasly-SemBioSys Bio-Pharmaceuticals Co., Ltd. was incorporated in Tianjin, China. The new company was structured as a Sino-Foreign Equity Joint Venture and seeks to develop and commercialize a variety of products including pharmaceutical, functional foods, and nutraceuticals for China and the world. However SemBioSys did not transfer any intellectual property to the joint venture and Tasly terminated the agreement. (en) |
| dbo:industry | dbr:Biotechnology |
| dbo:numberOfEmployees | 20 (xsd:nonNegativeInteger) |
| dbo:type | dbr:Public_company |
| dbo:wikiPageExternalLink | http://www.sembiosys.com https://web.archive.org/web/20111005104805/http:/www.sembiosys.com/ https://web.archive.org/web/20111014140433/http:/www.tasly.com/en_web/index.aspx |
| dbo:wikiPageID | 4369174 (xsd:integer) |
| dbo:wikiPageLength | 5365 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID | 1087215446 (xsd:integer) |
| dbo:wikiPageWikiLink | dbr:Canada dbr:Proteins dbr:ApoA-1_Milano dbr:Humulin dbr:Pharmaceutical dbr:University_of_Calgary dbr:Dow_AgroSciences dbr:Public_company dbr:Pharming_(genetics) dbr:Nutraceutical dbr:Traditional_Chinese_medicines dbr:Functional_beverage dbr:Functional_food dbr:Maurice_Moloney dbr:Business_Development_Bank_of_Canada dbr:Tianjin dbr:Agricultural dbr:Dow_Chemical_Company dbc:Biotechnology_companies_of_Canada dbr:Biotechnology dbr:Plant-made_pharmaceuticals dbr:Nutraceuticals dbr:Insulin dbr:Oils dbr:Calgary,_Alberta dbr:Personal_care dbr:Safflower dbr:Tasly_Pharmaceuticals dbr:RBC_Capital_Partners dbr:Biosimilar_insulin |
| dbp:homepage | http://www.sembiosys.com |
| dbp:industry | Biotechnology (en) |
| dbp:keyPeople | James Szarko, President and CEO (en) |
| dbp:locationCity | dbr:Calgary,_Alberta |
| dbp:locationCountry | dbr:Canada |
| dbp:name | SemBioSys Genetics Inc. (en) |
| dbp:numEmployees | Approximately 20 (en) |
| dbp:type | dbr:Public_company |
| dbp:wikiPageUsesTemplate | dbt:Infobox_company dbt:Reflist dbt:Short_description |
| dct:subject | dbc:Biotechnology_companies_of_Canada |
| rdf:type | owl:Thing dbo:Company schema:Organization dul:Agent dul:SocialPerson dbo:Agent wikidata:Q24229398 wikidata:Q43229 wikidata:Q4830453 yago:WikicatBiotechnologyCompaniesOfCanada yago:Abstraction100002137 yago:Company108058098 yago:Group100031264 yago:Institution108053576 yago:Organization108008335 yago:YagoLegalActor yago:YagoLegalActorGeo yago:YagoPermanentlyLocatedEntity dbo:Organisation yago:SocialGroup107950920 |
| rdfs:comment | SemBioSys Genetics Inc. was a development stage agricultural biotechnology company. It utilized its patented safflower pharming platform to develop and make proteins and oils for the nutraceutical, functional food and beverage, and pharmaceutical industries. A University of Calgary spin-off (1994), SemBioSys became a publicly traded firm. Investors had included Bay City Capital, the Business Development Bank of Canada, Dow AgroSciences (a Canadian subsidiary of The Dow Chemical Company), Royal Bank Ventures Inc. (now RBC Capital Partners), the University of Calgary, Ventures West Capital Ltd., and Dr. Maurice Moloney. In May 2012, SemBioSys terminated its operations. (en) |
| rdfs:label | SemBioSys Genetics (en) |
| owl:sameAs | freebase:SemBioSys Genetics yago-res:SemBioSys Genetics wikidata:SemBioSys Genetics https://global.dbpedia.org/id/4ukZN |
| prov:wasDerivedFrom | wikipedia-en:SemBioSys_Genetics?oldid=1087215446&ns=0 |
| foaf:homepage | http://www.sembiosys.com |
| foaf:isPrimaryTopicOf | wikipedia-en:SemBioSys_Genetics |
| foaf:name | SemBioSys Genetics Inc. (en) |
| is dbo:wikiPageRedirects of | dbr:SemBioSys_Genetics_Inc. dbr:SemBioSys_Genetics_Inc._(Calgary) |
| is dbo:wikiPageWikiLink of | dbr:ApoA-1_Milano dbr:SemBioSys_Genetics_Inc. dbr:SemBioSys_Genetics_Inc._(Calgary) |
| is foaf:primaryTopic of | wikipedia-en:SemBioSys_Genetics |